World's Best Scientists 2026 revealed!
Award Badge
Immunology
Netherlands
2026
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Immunology

D-Index
137
Citations
71698
World Ranking
177
National Ranking
5

Medicine

D-Index
139
Citations
72609
World Ranking
1761
National Ranking
64

Carl G. Figdor publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carl G. Figdor sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 678 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carl G. Figdor D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carl G. Figdor sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 137 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Netherlands Leader Award
  • 2025 - Research.com Immunology in Netherlands Leader Award
  • 2023 - Research.com Medicine in Netherlands Leader Award
  • 2022 - Research.com Immunology in Netherlands Leader Award
  • 2012 - Member of Academia Europaea
  • 2008 - Royal Netherlands Academy of Arts and Sciences
  • 2006 - Spinoza Prize, Dutch Research Council

Overview

Carl G. Figdor is affiliated with Radboud University in the Netherlands. Their research spans several interconnected fields, predominantly focusing on Immunology and Microbiology, Medicine, and Biochemistry, Genetics and Molecular Biology. Their work emphasizes the subfields of Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Biomaterials.

The scientist's main research topics include:

  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers
  • T-cell and B-cell Immunology
  • Nanoparticle-Based Drug Delivery

Figdor has contributed to various scholarly articles published in notable venues. Frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Journal for ImmunoTherapy of Cancer
  • ACS Nano
  • OncoImmunology

Recent publications exemplify the scope and depth of their research:

  • PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up, 2021, International Journal of Pharmaceutics
  • Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity, 2021, Nature Communications
  • The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture, 2020, Nature Communications
  • Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation, 2022, ACS Nano
  • Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial, 2020, Cancer Immunology Immunotherapy

Figdor collaborates frequently with several researchers, including:

  • I. Jolanda M. de Vries
  • Martijn Verdoes
  • Johannes Textor
  • Marjolein Schluck
  • Mark A.J. Gorris

The scientist has received multiple awards through their career, such as:

  • Member of Academia Europaea, 2012
  • Royal Netherlands Academy of Arts and Sciences, 2008
  • Spinoza Prize, Dutch Research Council, 2006

Best Publications

  • Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

    R de Waal Malefyt;J Abrams;B Bennett;C G Figdor

  • DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

    T.B.H. Geijtenbeek;D.S. Kwon;R. Torensma;S.J. van Vliet

  • Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses

    T.B.H. Geijtenbeek;R. Torensma;S.J. van Vliet;G.C.F. van Duijnhoven

  • Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

    R de Waal Malefyt;J Haanen;H Spits;M G Roncarolo

  • Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force

    Katarina Wolf;Mariska te Lindert;Marina Krause;Stephanie Alexander

  • Dendritic cell immunotherapy: mapping the way

    Carl G Figdor;I Jolanda M de Vries;W Joost Lesterhuis;Cornelis J M Melief

  • C-type lectin receptors on dendritic cells and langerhans cells

    Carl G Figdor;Yvette van Kooyk;Gosse J Adema

  • Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

    I Jolanda M de Vries;W Joost Lesterhuis;Jelle O Barentsz;Pauline Verdijk

  • Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

    Paul J. Tacken;I. Jolanda M. de Vries;Ruurd Torensma;Carl G. Figdor

  • Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10.

    R de Waal Malefyt;C G Figdor;R Huijbens;S Mohan-Peterson

  • The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells.

    Anneke Engering;Teunis B. H. Geijtenbeek;Sandra J. van Vliet;Mietske Wijers

  • Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

    A.B.H. Bakker;M.W.J. Schreurs;A.J. de Boer;Y. Kawakami

  • Different faces of the heme-heme oxygenase system in inflammation

    Frank A. D. T. G. Wagener;Hans-Dieter Volk;Dean Willis;Nader G. Abraham

  • A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells

    G.J. Adema;F.C. Hartgers;R.G.G. Verstraten;E. de Vries

  • DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking

    T.B.H. Geijtenbeek;D.J.E.B. Krooshoop;D.A. Bleijs;S.J. van Vliet

  • Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state

    I. Jolanda M. de Vries;Daniëlle J. E. B. Krooshoop;Nicole M. Scharenborg;W. Joost Lesterhuis

  • Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes.

    Y van Kooyk;P van de Wiel-van Kemenade;P Weder;T W Kuijpers

  • In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity

    Martijn H. M. G. M. den Brok;Roger P. M. Sutmuller;Robbert van der Voort;Erik J. Bennink

  • Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes.

    A.A. te Velde;R.J.F. Huijbens;K. Heije;J.E. de Vries

  • Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase.

    Frank A. D. T. G. Wagener;Andreas Eggert;Otto C. Boerman;Wim J. G. Oyen

  • DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking

    T.B. Geijtenbeek;D.J.E.B. Krooshoop;D.A. Bleijs;S. van Vliet

Frequent Co-Authors

I. Jolanda M. de Vries
I. Jolanda M. de Vries Radboud University
Ruurd Torensma
Ruurd Torensma Radboud University
Gosse J. Adema
Gosse J. Adema Radboud University
Cornelis J. A. Punt
Cornelis J. A. Punt University of Amsterdam
Gerty Schreibelt
Gerty Schreibelt Radboud University
Vinod Subramaniam
Vinod Subramaniam Vrije Universiteit Amsterdam
Winald R. Gerritsen
Winald R. Gerritsen Radboud University
Yvette van Kooyk
Yvette van Kooyk Vrije Universiteit Amsterdam
Wim J.G. Oyen
Wim J.G. Oyen Humanitas University
Maria F. Garcia-Parajo
Maria F. Garcia-Parajo Institute of Photonic Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related health care degrees can open diverse career paths. Many students complement their immunology knowledge with practical nursing programs that offer accelerated tracks. For example, choosing from the easiest accelerated nursing programs to get into helps students enter the workforce quickly while gaining essential clinical skills.

Another foundational route is enrolling in LPN programs, which provide a solid base in patient care and immunological health considerations. The lpn programs easy to get into are particularly attractive for those seeking quick access and hands-on experience in healthcare settings.

Advancing further, nurse practitioner degrees offer an excellent blend of clinical practice and patient management, some of which focus specifically on mental health. Students may find options through the easiest nurse practitioner program listings ideal for balancing study with professional growth.

For those aiming to specialize in psychiatric care within immunology-related contexts, exploring the best psychiatric mental health nurse practitioner programs online ensures valuable clinical placements and tailored training.

These pathways collectively support a robust foundation in immunology while enhancing professional opportunities in healthcare.

Best Scientists Citing Carl G. Figdor

Trending Scientists

Recently Published Articles